Previous close | 97.56 |
Open | 97.74 |
Bid | 0.00 x 800 |
Ask | 0.00 x 800 |
Day's range | 96.76 - 98.49 |
52-week range | 70.82 - 99.55 |
Volume | |
Avg. volume | 340,361 |
Market cap | 4.905B |
Beta (5Y monthly) | 0.92 |
PE ratio (TTM) | 27.03 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.62 (1.66%) |
Ex-dividend date | 31 May 2024 |
1y target est | N/A |
Ashland (ASH) is set to sell its nutraceuticals business to Turnspire Capital Partners, with the deal expected to close in third-quarter 2024.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here is how Ashland (ASH) and Buenaventura (BVN) have performed compared to their sector so far this year.